Brain Tumor Diagnosis and Treatments Market by Key
Segments | Forecast Years:
2022-
2027
| CAGR:8.65%
{reportSlug=global-brain-tumor-diagnosis-and-treatments-market, reportId=86019, mktKeyword=Brain Tumor Diagnosis and Treatments, cagr=8.65, publishDate=May 2022, priceOption2=7500, reportTitle=Brain Tumor Diagnosis and Treatments Comprehensive Study by Type (Primary Brain Tumor (Meningioma, Gliomas, Astrocytomas, Pituitary Tumors, Other Primary Brain Tumors), Secondary Brain Tumor), Application (Hospital, Medical center), Drug Type (Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib), Diagnosis Testing (PET-CT scan, MRI, CT scan, EEG, Molecular testing, Others), Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), Type of Brain Tumor (Anaplastic astrocytoma, Anaplastic oligodendroglioma, Low-grade (diffuse) astrocytoma, Ependymoma, Glioblastoma, Oligodendroglioma) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=186, priceOption1=3750, forecastYr=2027, noOfPages=134, reportKey=85578, breadcrum=Global Brain Tumor Diagnosis and Treatments Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
May 2022
134 Pages
53 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries